Based on traditional reports of the use of plants of the genus Paeonia in the treatment of epilepsy, we have screened extracts of the roots of three Greek Paeonia species (P. parnassica, P. mascula subsp. hellenica, P. clusii subsp. clusii) for anticonvulsant activity. This led to the identification of some interesting prophylactic anticonvulsant activity of the extracts of P. parnassica. From the roots of this species, seventeen compounds were subsequently isolated and identified. Amongst these, seven contained the characteristic cage-like terpenic skeleton that is found only in plants of the genus Paeonia. Two of the above products: 4-Ο-methylpaeoniflorin (1) and paeonidanin (2) are described for the first time as natural products. The structures of all compounds have been elucidated on the basis of their spectral data.
Since antiquity the use of plants of the genus Paeonia (Paeoniaceae) has been reported in traditional treatments for epilepsy conditions. Some of the oldest prescriptions known are described by Dioscorides in the 1st century A.C. [1] . The pharmacological activities of extracts of Paeonia species and their constituents, especially the paeoniflorin-related ones, are numerous and are still under investigation [2, 3] . Paeonia plants (primarily the roots of P. albiflora) are still widely used in Chinese medicine against many diseases of the nervous system [4] . Screening extracts of the roots of three Greek Paeonia species (P. parnassica Tzanoud., Paeonia mascula (L.) Mill. subsp. hellenic Tzanoud., P. clusii Stern & Stearn subsp. clusii) resulted in the identification of some interesting prophylactic anticonvulsant activity. This information led to further phytochemical investigation of the most active extracts of P. parnassica. This plant is endemic to the mountains of Greece (Parnassos and Elikon). In previous work we described the volatiles extracted from its roots and reported their potential antimicrobial activities [5] .
The current phytochemical study of the dichloromethane, methanol and water extracts of the roots of P. parnassica led to both isolation and identification of 17 constituents: β-sitosterol [6] , paeoniflorigenone [7] , palbinone [8] , sitosterol-3-Οβ-D-glucopyranoside [9, 10] , benzoylpaeoniflorin [7] , paeoniflorin [11] [12] [13] [14] , 3',5'-dimethoxy-4'-Ο-β-Dglucopyranosyl-cinnamic acid [15] , uridine [16, 17] , vanilloloside [18] , 3,5-dimethoxy-4-hydroxybenzyl alcohol 4-Ο-β-D-glucopyranoside [19] , paeonicluside [7] , oxypaeoniflorin [13, 20] , 8-debenzoylpaeoniflorin [21] , gallic methylester [22] , 4-O-methylpaeoniflorin (1), paeonidanin (2) and albiflorin (3) [11, 20] .
Compounds 1 and 2 (Figure 1) are described for the first time as natural products [23, 24] . Apart from 1 and 2, this is the first report of 3',5'-dimethoxy-4'-Οβ-D-glucopyranosyl-cinnamic acid, vanilloloside and 3,5-dimethoxy-4-hydroxybenzyl alcohol 4-Ο-β-Dglucopyranoside in the Paeoniaceae family. Furthermore, 3 is a compound known for its anticonvulsant activity [25] . NMR spectrum of 1 with that of paeoniflorin revealed that the only important difference was one singlet observed at δ 3.32 corresponding to three deshielded protons of a methoxyl group. The presence of the methoxyl group at the position 4 was confirmed with the 13 C NMR and HMBC spectra. The 13 C NMR spectrum showed the presence of a carbon at δ 51.5. The HMBC spectrum revealed a 3 J correlation between the three protons observed at δ 3.32 and the carbon observed at 109.47 ppm (C-4). Additionally the HMBC spectrum confirmed the positioning of the benzoyl unit at C-8 and of the glucose at C-1 through the 3 J correlation of H-8 with C-7´´, and H-1´ with C-1, respectively.
These data provided the evidence to confirm that 1 was 4-O-methylpaeoniflorin. This substance is reported here for the first time as a natural product, although it had been described as a semisynthetic derivative of paeoniflorin [23] , with identical stereochemistry. It should also be noted that 1 was not detected in any of the extracts of the other two Paeonia species.
Compound 2 was also obtained as an amorphous yellowish solid. Its molecular formula was determined by ESMS and NMR spectroscopic data as C 24 H 30 O 11 . The most important difference from compound 1 in the 1 H NMR spectrum was the presence of two doublets at δ 4.75 and δ 4.86 respectively, instead of one singlet at δ 4.71 (H-8), which lead us to the assumption that this compound has a skeleton similar to that of albiflorin (3). The 13 C NMR spectrum showed the presence of a carbonyl group, as there was a carbon signal at δ 209.54. In the HMBC spectrum the carbon of the carbonyl group showed a 2 J correlation with the protons observed at δ 2.53, 2.92 and 2.99 (H-3, 5) and a 3 J correlation with the protons observed at δ 2.19 and 2.97 (H-6). Consequently, the presence of a carbonyl group in the position 4 was confirmed. In addition, the proton observed at δ 5.13 was correlated with four carbons observed at δ 47.71, 55.8, 63.88 and 88.51, respectively, which lead us to the conclusion that there is a methoxyl group at position 9. The positioning of the benzoyl unit at C-8 and of the glucose at C-1 was confirmed by the 3 J correlation of H-8 with C-7´´, and H-1´ with C-1, respectively in the HMBC spectrum. This molecule is also described for the first time as a natural product, although its semi-synthetic peracetylated derivative had been previously reported [24] . Acetylation of 2 and comparison with the literature data [24] verified the structure and the stereochemistry of 2.
Concerning the anticonvulsant activity, only the extracts of P. parnassica showed notable activity in the 6 Hz test using 32 mA and 22 mA. The water extract of the plant was found to be the most active, which is in accordance with previous studies performed in other Paeonia species [25] . The methanol extract, although showing signs of protection was less potent than the water extract. The activity observed for P. parnassica extracts could be at least partially correlated with the presence of albiflorin, which is a compound with purported anticonvulsant activity [25] . This correlation is in accordance with the observation that the less active extracts of P. mascula subsp. hellenica and P. clusii subsp. clusii contained less than 0.05% or nondetectable quantities, and less than 0.001% of the albiflorin ingredient, respectively, as measured by analytical HPLC. These test results are presented in Table 1 . 
4-O-methylpaeoniflorin (1)
Amorphous yellowish solid.
[α] D : -18.5º (c 0.4 g/100 mL, MeOH). 1 Paeonidanin (2) Amorphous yellowish solid.
[α] D : -31.3º (c 0.4 g/100 mL, MeOH). 1 20 and 30 grams were used for these experiments. Each time point was represented by four animals with a minimum of twenty animals employed. Animals were housed in rooms controlled for both temperature and light for periods of twelve hours on and twelve hours off. The mice had free access to food and water except during the actual time of the experiment. Test extracts or compounds were pre-administered to mice via i.p. injection at a dose of 100 mg/Kg. A solution of 0.5% tetracaine was also applied to the eyes of all tested animals. Animals were challenged with sufficient current delivered through corneal electrodes to elicit a psychomotor seizure in 97% of animals (22 and 32 mA for 3 seconds) [26] [27] .
Untreated mice would display seizures characterized by a minimal clonic phase followed by stereotyped, automatistic behaviors described originally as being similar to the aura of human patients with partial seizures. Animals not displaying this behavior were considered protected. Results are expressed as the number of animals protected out of the number of animals tested over time. The tested extracts were considered active if there are at least 2/4 protected animals at two or more time points. At the end of these experiments animals were sacrificed according to guidelines approved by AAALAC.
